Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for AXSM

Stock Name	Axsome Therapeutics Inc
Ticker	AXSM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US05464T1043
LEI	549300EXGR0XLRJEIB95

Show aggregate AXSM holdings

News associated with AXSM

Peek Under The Hood: JHMM Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:11:32
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock: Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Roger Jeffs sold 13,464 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $123.68, for a total value of $1,665,227.52. Following the completion of the sale, the director owned 57,510 shares in […] - 2025-09-04 05:23:00
Deutsche Bank AG Lowers Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Deutsche Bank AG reduced its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 21.2% during the first quarter, Holdings Channel reports. The institutional investor owned 94,980 shares of the company’s stock after selling 25,567 shares during the period. Deutsche Bank AG’s holdings in Axsome Therapeutics were worth $11,078,000 as of its […] - 2025-08-15 05:17:09
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $189.00 at Royal Bank Of Canada: Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective increased by analysts at Royal Bank Of Canada from $184.00 to $189.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 83.03% from the […] - 2025-08-07 05:30:53
KLP Kapitalforvaltning AS Decreases Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM): KLP Kapitalforvaltning AS reduced its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.8% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,200 shares of the company’s stock after selling 600 shares during the period. KLP Kapitalforvaltning AS’s holdings in Axsome Therapeutics were worth […] - 2025-07-29 05:28:50
Cerity Partners LLC Raises Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Cerity Partners LLC lifted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 15.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 5,707 shares of the company’s stock after purchasing an additional 766 shares during the period. Cerity Partners LLC’s holdings in Axsome Therapeutics were worth $666,000 as of […] - 2025-07-25 04:50:58
12,745 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Acquired by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd purchased a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 12,745 shares of the company’s stock, valued at approximately $1,486,000. A number of other hedge funds have also recently made changes to their positions in AXSM. HighTower Advisors LLC […] - 2025-07-24 06:02:49
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement Fund: New York State Common Retirement Fund raised its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 49.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,581 shares of the company’s stock after buying an additional 11,090 […] - 2025-07-22 07:13:06
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,623 shares of the company’s stock after acquiring an additional 136 […] - 2025-07-17 05:39:38
D.A. Davidson & CO. Has $788,000 Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): D.A. Davidson & CO. reduced its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 17.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,755 shares of the company’s stock after selling 1,475 shares during the quarter. D.A. Davidson […] - 2025-07-10 05:31:08
Head-To-Head Review: Axsome Therapeutics (NASDAQ:AXSM) vs. Rosetta Genomics (OTCMKTS:ROSGQ): Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) and Rosetta Genomics (OTCMKTS:ROSGQ – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Risk and Volatility Axsome Therapeutics has a beta […] - 2025-07-07 02:28:50
Janney Montgomery Scott LLC Has $1.74 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Janney Montgomery Scott LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 8.6% in the 1st quarter, HoldingsChannel reports. The fund owned 14,923 shares of the company’s stock after buying an additional 1,178 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Axsome Therapeutics were worth $1,740,000 at the end […] - 2025-06-27 04:26:52
AXSM Makes Notable Cross Below Critical Moving Average: In trading on Monday, shares of Axsome Therapeutics Inc (Symbol: AXSM) crossed below their 200 day moving average of $102.28, changing hands as low as $101.01 per share. Axsome Therapeutics Inc shares are currently trading down about 1.9% on the day. The chart below shows the - 2025-06-16 12:41:26
GAMMA Investing LLC Increases Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): GAMMA Investing LLC increased its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 38,571.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,043 shares of the company’s stock after buying an additional 21,986 shares during the quarter. GAMMA Investing […] - 2025-06-13 05:14:47
Rhumbline Advisers Grows Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Rhumbline Advisers boosted its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,760 shares of the company’s stock after acquiring an additional 3,515 shares during the quarter. Rhumbline Advisers’ holdings in Axsome Therapeutics […] - 2025-06-12 05:31:01
HC Wainwright Reiterates “Buy” Rating for Axsome Therapeutics (NASDAQ:AXSM): Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $180.00 target price on the stock. HC Wainwright’s price target would suggest a potential upside of 66.54% from the stock’s previous close. Several other […] - 2025-06-12 02:18:55
Needham & Company LLC Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $150.00: Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective decreased by Needham & Company LLC from $153.00 to $150.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 36.48% from the […] - 2025-06-11 02:44:51
2 Soaring Stocks Wth More Upside Potential: Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to Summit - 2025-06-05 04:19:00
Nuveen Asset Management LLC Increases Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Nuveen Asset Management LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 118.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 221,202 shares of the company’s stock after acquiring an additional 119,780 shares during the period. Nuveen Asset Management LLC’s holdings in Axsome Therapeutics were worth $18,716,000 as of its […] - 2025-05-25 06:03:20
Captrust Financial Advisors Sells 2,769 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM): Captrust Financial Advisors decreased its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 48.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,953 shares of the company’s stock after selling 2,769 shares during the period. Captrust Financial Advisors’ holdings in Axsome Therapeutics […] - 2025-05-22 04:47:00
Comerica Bank Sells 3,570 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM): Comerica Bank trimmed its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 32.6% during the 4th quarter, HoldingsChannel reports. The firm owned 7,374 shares of the company’s stock after selling 3,570 shares during the quarter. Comerica Bank’s holdings in Axsome Therapeutics were worth $624,000 at the end of the most recent reporting period. […] - 2025-05-15 04:52:49
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $162.00: Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price lifted by Robert W. Baird from $160.00 to $162.00 in a report released on Tuesday, Marketbeat reports. Robert W. Baird currently has an outperform rating on the stock. Other research analysts have also recently issued research reports about the company. HC Wainwright reaffirmed a “buy” […] - 2025-05-09 03:56:43
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by Price T Rowe Associates Inc. MD: Price T Rowe Associates Inc. MD raised its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 12.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 31,228 shares of the company’s stock after acquiring an additional 3,366 shares during the period. Price T Rowe Associates […] - 2025-05-07 05:50:49
Axsome Therapeutics (NASDAQ:AXSM) Trading Up 5.6% After Earnings Beat: Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price was up 5.6% during trading on Monday following a better than expected earnings announcement. The stock traded as high as $117.60 and last traded at $118.54. Approximately 231,459 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 683,737 […] - 2025-05-07 02:24:42
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 10:32:49
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 08:45:35
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 06:31:04
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 03:51:04
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 02:59:18
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 01:28:32

iShares Healthcare Innovation UCITS ETF USD (Acc) AXSM holdings

Date	Number of AXSM Shares Held	Base Market Value of AXSM Shares	Local Market Value of AXSM Shares	Change in AXSM Shares Held	Change in AXSM Base Value	Current Price per AXSM Share Held	Previous Price per AXSM Share Held
2025-11-27 (Thursday)	46,184	USD 6,972,860	USD 6,972,860	0	USD 0	USD 150.98	USD 150.98
2025-11-26 (Wednesday)	46,184	USD 6,972,860	USD 6,972,860	0	USD 28,634	USD 150.98	USD 150.36
2025-11-25 (Tuesday)	46,184	USD 6,944,226	USD 6,944,226	0	USD -38,795	USD 150.36	USD 151.2
2025-11-24 (Monday)	46,184	USD 6,983,021	USD 6,983,021	0	USD 81,284	USD 151.2	USD 149.44
2025-11-21 (Friday)	46,184	USD 6,901,737	USD 6,901,737	0	USD 283,108	USD 149.44	USD 143.31
2025-11-20 (Thursday)	46,184	USD 6,618,629	USD 6,618,629	0	USD -159,797	USD 143.31	USD 146.77
2025-11-19 (Wednesday)	46,184	USD 6,778,426	USD 6,778,426	0	USD -32,790	USD 146.77	USD 147.48
2025-11-18 (Tuesday)	46,184	USD 6,811,216	USD 6,811,216	0	USD 88,673	USD 147.48	USD 145.56
2025-11-17 (Monday)	46,184	USD 6,722,543	USD 6,722,543	0	USD 271,100	USD 145.56	USD 139.69
2025-11-14 (Friday)	46,184	USD 6,451,443	USD 6,451,443	-402	USD 50,527	USD 139.69	USD 137.4
2025-11-13 (Thursday)	46,586	USD 6,400,916	USD 6,400,916	0	USD -161,188	USD 137.4	USD 140.86
2025-11-12 (Wednesday)	46,586	USD 6,562,104	USD 6,562,104	0	USD 58,233	USD 140.86	USD 139.61
2025-11-11 (Tuesday)	46,586	USD 6,503,871	USD 6,503,871	0	USD 84,320	USD 139.61	USD 137.8

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AXSM by Blackrock for IE00BYZK4776

Show aggregate share trades of AXSM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-14 SELL -402 141.970 136.000 136.597 USD -54,912 111.87 Loss of -9,942 on sale
2025-10-24 SELL -394 129.550 130.630 130.522 USD -51,426 109.91 Loss of -8,123 on sale
2025-09-11 BUY 198 122.960 124.510 124.355 USD 24,622 108.38
2025-07-08 SELL -197 108.410 110.440 110.237 USD -21,717 107.81 Loss of -477 on sale
2025-06-24 SELL -198 104.260 105.025 104.949 USD -20,780 108.02 Profit of 609 on sale
2025-06-23 SELL -198 101.650 104.005 103.769 USD -20,546 108.07 Profit of 852 on sale
2025-06-20 BUY 1,341 100.690 103.915 103.593 USD 138,918 108.12
2025-06-11 SELL -192 108.080 111.150 110.843 USD -21,282 108.35 Loss of -479 on sale
2025-05-30 SELL -192 105.160 105.550 105.511 USD -20,258 108.29 Profit of 534 on sale
2025-05-21 BUY 192 105.760 108.810 108.505 USD 20,833 108.52
2025-05-14 SELL -1,152 103.670 106.845 106.528 USD -122,720 108.57 Profit of 2,357 on sale
2025-04-30 SELL -192 112.290 113.000 112.929 USD -21,682 108.35 Loss of -879 on sale
2025-04-28 SELL -192 107.240 109.710 109.463 USD -21,017 108.35 Loss of -214 on sale
2025-04-25 SELL -192 106.270 106.800 106.747 USD -20,495 108.37 Profit of 311 on sale
2025-04-11 SELL -1,158 98.060 98.455 98.416 USD -113,965 108.78 Profit of 12,005 on sale
2025-04-08 SELL -576 97.550 103.000 102.455 USD -59,014 109.14 Profit of 3,848 on sale
2025-04-07 BUY 312 98.500 102.200 101.830 USD 31,771 109.26
2025-03-31 SELL -378 116.630 117.780 117.665 USD -44,477 109.26 Loss of -3,178 on sale
2025-03-21 SELL -378 126.790 128.500 128.329 USD -48,508 108.23 Loss of -7,597 on sale
2025-03-12 SELL -190 119.450 122.510 122.204 USD -23,219 106.71 Loss of -2,944 on sale
2025-02-28 SELL -190 127.540 128.770 128.647 USD -24,443 104.54 Loss of -4,580 on sale
2025-02-25 BUY 190 127.090 131.990 131.500 USD 24,985 103.40
2025-02-20 SELL -190 129.100 129.410 129.379 USD -24,582 101.87 Loss of -5,226 on sale
2025-02-19 BUY 380 126.960 130.520 130.164 USD 49,462 101.42
2025-02-18 BUY 190 128.090 130.148 129.942 USD 24,689 100.94
2024-12-30 BUY 536 84.780 84.980 84.960 USD 45,539 94.64
2024-12-06 SELL -186 100.100 100.240 100.226 USD -18,642 94.18 Loss of -1,124 on sale
2024-12-04 SELL -186 99.540 102.420 102.132 USD -18,997 93.87 Loss of -1,538 on sale
2024-12-03 SELL -372 100.490 102.000 101.849 USD -37,888 93.64 Loss of -3,055 on sale
2024-11-21 SELL -187 98.190 99.350 99.234 USD -18,557 91.21 Loss of -1,501 on sale
2024-11-20 SELL -188 94.600 96.920 96.688 USD -18,177 91.02 Loss of -1,066 on sale
2024-11-19 SELL -188 95.460 95.545 95.536 USD -17,961 90.76 Loss of -898 on sale
2024-11-18 SELL -744 92.450 95.000 94.745 USD -70,490 90.65 Loss of -3,046 on sale
2024-11-12 SELL -186 99.490 101.505 101.303 USD -18,842 90.06 Loss of -2,091 on sale
2024-11-07 SELL -186 90.700 92.549 92.364 USD -17,180 90.01 Loss of -437 on sale
2024-11-05 SELL -372 89.240 89.420 89.402 USD -33,258 90.00 Profit of 221 on sale
2024-10-28 SELL -186 90.110 92.500 92.261 USD -17,161 90.98 Loss of -238 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-14	SELL	-402	141.970	136.000	136.597	USD -54,912	111.87 Loss of -9,942 on sale
2025-10-24	SELL	-394	129.550	130.630	130.522	USD -51,426	109.91 Loss of -8,123 on sale
2025-09-11	BUY	198	122.960	124.510	124.355	USD 24,622	108.38
2025-07-08	SELL	-197	108.410	110.440	110.237	USD -21,717	107.81 Loss of -477 on sale
2025-06-24	SELL	-198	104.260	105.025	104.949	USD -20,780	108.02 Profit of 609 on sale
2025-06-23	SELL	-198	101.650	104.005	103.769	USD -20,546	108.07 Profit of 852 on sale
2025-06-20	BUY	1,341	100.690	103.915	103.593	USD 138,918	108.12
2025-06-11	SELL	-192	108.080	111.150	110.843	USD -21,282	108.35 Loss of -479 on sale
2025-05-30	SELL	-192	105.160	105.550	105.511	USD -20,258	108.29 Profit of 534 on sale
2025-05-21	BUY	192	105.760	108.810	108.505	USD 20,833	108.52
2025-05-14	SELL	-1,152	103.670	106.845	106.528	USD -122,720	108.57 Profit of 2,357 on sale
2025-04-30	SELL	-192	112.290	113.000	112.929	USD -21,682	108.35 Loss of -879 on sale
2025-04-28	SELL	-192	107.240	109.710	109.463	USD -21,017	108.35 Loss of -214 on sale
2025-04-25	SELL	-192	106.270	106.800	106.747	USD -20,495	108.37 Profit of 311 on sale
2025-04-11	SELL	-1,158	98.060	98.455	98.416	USD -113,965	108.78 Profit of 12,005 on sale
2025-04-08	SELL	-576	97.550	103.000	102.455	USD -59,014	109.14 Profit of 3,848 on sale
2025-04-07	BUY	312	98.500	102.200	101.830	USD 31,771	109.26
2025-03-31	SELL	-378	116.630	117.780	117.665	USD -44,477	109.26 Loss of -3,178 on sale
2025-03-21	SELL	-378	126.790	128.500	128.329	USD -48,508	108.23 Loss of -7,597 on sale
2025-03-12	SELL	-190	119.450	122.510	122.204	USD -23,219	106.71 Loss of -2,944 on sale
2025-02-28	SELL	-190	127.540	128.770	128.647	USD -24,443	104.54 Loss of -4,580 on sale
2025-02-25	BUY	190	127.090	131.990	131.500	USD 24,985	103.40
2025-02-20	SELL	-190	129.100	129.410	129.379	USD -24,582	101.87 Loss of -5,226 on sale
2025-02-19	BUY	380	126.960	130.520	130.164	USD 49,462	101.42
2025-02-18	BUY	190	128.090	130.148	129.942	USD 24,689	100.94
2024-12-30	BUY	536	84.780	84.980	84.960	USD 45,539	94.64
2024-12-06	SELL	-186	100.100	100.240	100.226	USD -18,642	94.18 Loss of -1,124 on sale
2024-12-04	SELL	-186	99.540	102.420	102.132	USD -18,997	93.87 Loss of -1,538 on sale
2024-12-03	SELL	-372	100.490	102.000	101.849	USD -37,888	93.64 Loss of -3,055 on sale
2024-11-21	SELL	-187	98.190	99.350	99.234	USD -18,557	91.21 Loss of -1,501 on sale
2024-11-20	SELL	-188	94.600	96.920	96.688	USD -18,177	91.02 Loss of -1,066 on sale
2024-11-19	SELL	-188	95.460	95.545	95.536	USD -17,961	90.76 Loss of -898 on sale
2024-11-18	SELL	-744	92.450	95.000	94.745	USD -70,490	90.65 Loss of -3,046 on sale
2024-11-12	SELL	-186	99.490	101.505	101.303	USD -18,842	90.06 Loss of -2,091 on sale
2024-11-07	SELL	-186	90.700	92.549	92.364	USD -17,180	90.01 Loss of -437 on sale
2024-11-05	SELL	-372	89.240	89.420	89.402	USD -33,258	90.00 Profit of 221 on sale
2024-10-28	SELL	-186	90.110	92.500	92.261	USD -17,161	90.98 Loss of -238 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AXSM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	68,445	300	138,492	49.4%
2025-09-18	68,724	0	169,529	40.5%
2025-09-17	76,197	40	235,412	32.4%
2025-09-16	165,940	84	332,172	50.0%
2025-09-15	92,091	46	186,500	49.4%
2025-09-12	170,518	1,480	325,952	52.3%
2025-09-11	88,854	16	216,018	41.1%
2025-09-10	61,160	0	187,155	32.7%
2025-09-09	142,408	200	299,185	47.6%
2025-09-08	144,320	0	285,049	50.6%
2025-09-05	104,449	0	205,294	50.9%
2025-09-04	73,216	1,801	138,763	52.8%
2025-09-03	141,477	0	223,165	63.4%
2025-09-02	170,723	300	297,328	57.4%
2025-08-29	64,424	1,970	131,926	48.8%
2025-08-28	55,224	200	123,399	44.8%
2025-08-27	111,321	12	228,559	48.7%
2025-08-26	116,205	0	242,941	47.8%
2025-08-25	54,093	584	115,267	46.9%
2025-08-22	125,994	0	268,008	47.0%
2025-08-21	93,981	600	186,202	50.5%
2025-08-20	105,544	0	162,402	65.0%
2025-08-19	146,328	0	321,780	45.5%
2025-08-18	110,411	0	419,410	26.3%
2025-08-15	58,491	0	149,199	39.2%
2025-08-14	63,117	0	124,653	50.6%
2025-08-13	90,090	0	217,540	41.4%
2025-08-12	50,283	920	155,222	32.4%
2025-08-11	47,068	0	126,857	37.1%
2025-08-08	46,479	0	126,179	36.8%
2025-08-07	65,399	0	143,983	45.4%
2025-08-06	121,354	0	208,439	58.2%
2025-08-05	216,252	15	377,690	57.3%
2025-08-04	274,153	551	441,196	62.1%
2025-08-01	224,315	1,925	341,203	65.7%
2025-07-31	160,824	0	273,054	58.9%
2025-07-30	142,247	9	235,179	60.5%
2025-07-29	117,550	0	233,072	50.4%
2025-07-28	203,714	708	330,365	61.7%
2025-07-25	240,457	35	377,498	63.7%
2025-07-24	112,006	5	181,155	61.8%
2025-07-23	246,830	0	323,571	76.3%
2025-07-22	354,999	0	495,589	71.6%
2025-07-21	126,659	0	205,641	61.6%
2025-07-18	130,794	15	199,458	65.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE